Maria Adelaide Marini

Qualifica
ASSOCIATO CONFERMATO
Fonte dei dati: Archivio della Ricerca http://art.torvergata.it
  1. Fiorentino, T., Succurro, E., Marini, M., Pedace, E., Andreozzi, F., Perticone, M., et al. (2020). HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: a longitudinal study. DIABETES/METABOLISM RESEARCH AND REVIEWS, 36(4). Dettagli
  2. Fiorentino T., V., Succurro, E., Marini, M.A., Pedace, E., Andreozzi, F., Perticone, M., et al. (2020). Experimental evidence indicates that high‐density lipoprotein (HDL) may stimulate glucose uptake and improve β‐cell function. The aim of this study was to evaluate whether lower levels of HDL may affect the risk to develop type 2 diabetes. DIABETES/METABOLISM RESEARCH AND REVIEWS [10.1002/dmrr.3289]. Dettagli
  3. Fiorentino, T., Marini, M., Succurro, E., Andreozzi, F., & Sesti, G. (2019). Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage. BMJ OPEN DIABETES RESEARCH AND CARE. Dettagli
  4. Fiorentino, T., Marini, M., Succurro, E., Andreozzi, F., Perticone, M., Hribal, M., et al. (2019). Response to Letter to the Editor: "One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes". THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. Dettagli
  5. Lepore, G., Bonfanti, R., Bozzetto, L., Di Blasi, V., Girelli, A., Grassi, G., et al. (2018). Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 28(4), 335-342 [10.1016/j.numecd.2017.12.001]. Dettagli
  6. Fiorentino, T.v., Marini, M.a., Succurro, E., Andreozzi, F., Perticone, M., Hribal, M.l., et al. (2018). One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 103(9), 3131-3143 [10.1210/jc.2018-00468]. Dettagli
  7. Mannino, G.c., Fuoco, A., Marini, M.a., Spiga, R., Di Fatta, C., Mancuso, E., et al. (2018). The polymorphism rs35767 at IGF1 locus is associated with serum urate levels. SCIENTIFIC REPORTS, 8(1), 12255 [10.1038/s41598-018-29665-3]. Dettagli
  8. Fiorentino, T., Marini, M.a., Succurro, E., Sciacqua, A., Andreozzi, F., Perticone, F., et al. (2017). Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction. ONCOTARGET, 8(45), 79576-79586 [10.18632/oncotarget.18572]. Dettagli
  9. Marini, M.A., Mannino, G.c., Fiorentino, T.v., Andreozzi, F., Perticone, F., & Sesti, G. (2017). A polymorphism at IGF1 locus is associated with anemia. ONCOTARGET [10.18632/oncotarget.16132]. Dettagli
  10. Fiorentino, T.v., Marini, M.a., Succurro, E., Andreozzi, F., Sciacqua, A., Hribal, M.l., et al. (2017). Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. DIABETES RESEARCH AND CLINICAL PRACTICE, 134, 53-61 [10.1016/j.diabres.2017.09.017]. Dettagli
  11. Marini, M.a., Fiorentino, T., Andreozzi, F., Mannino, G., Perticone, M., Sciacqua, A., et al. (2017). Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. ACTA DIABETOLOGICA, 54(8), 775-784 [10.1007/s00592-017-1004-z]. Dettagli
  12. Marini, M.a., Fiorentino, T., Andreozzi, F., Mannino, G., Succurro, E., Sciacqua, A., et al. (2017). Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 27(7), 601-608 [10.1016/j.numecd.2017.04.001]. Dettagli
  13. Marini, M.a., Fiorentino, T.v., Succurro, E., Pedace, E., Andreozzi, F., Sciacqua, A., et al. (2017). Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLOS ONE, 12(4), e0175547 [10.1371/journal.pone.0175547]. Dettagli
  14. Spiga, R., Marini, M.a., Mancuso, E., Di Fatta, C., Fuoco, A., Perticone, F., et al. (2017). Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, ATVBAHA.117.309128 [10.1161/ATVBAHA.117.309128]. Dettagli
  15. Fiorentino, T.v., Marini, M.A., Andreozzi, F., Arturi, F., Succurro, E., Perticone, M., et al. (2016). Response to the Letter: Comment to the letter by Marathe CS, Rayne CK, Jones KL, Horowitz M. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 101(2), L35-L35 [10.1210/jc.2015-4298]. Dettagli
  16. Maurizi, A., Suraci, C., Pitocco, D., Schiaffini, R., Tubili, C., Morviducci, L., et al. (2016). Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience. JOURNAL OF DIABETES, 8(1), 41-44 [10.1111/1753-0407.12321]. Dettagli
  17. Fiorentino, T., Marini, M., Andreozzi, F., Arturi, F., Succurro, E., Perticone, M., et al. (2015). One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 100(10), 3744-3751 [10.1210/jc.2015-2573]. Dettagli
  18. Marini, M., Frontoni, S., Succurro, E., Arturi, F., Fiorentino, T., Sciacqua, A., et al. (2014). Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. ACTA DIABETOLOGICA, 51(2), 257-261 [10.1007/s00592-013-0511-9]. Dettagli
  19. Sesti, G., Andreozzi, F., Fiorentino, T., Mannino, G., Sciacqua, A., Marini, M., et al. (2014). High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. ACTA DIABETOLOGICA [10.1007/s00592-014-0576-0]. Dettagli
  20. Marini, M.A., Frontoni, S., Succurro, E., Arturi, F., Sciacqua, A., Hribal, M., et al. (2014). Insulin sensitivity, and β-cell function in relation to hemoglobin A1C. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 24(1), 27-33 [10.1016/j.numecd.2013.01.011]. Dettagli
  21. Sesti, G., Mannino, G., Andreozzi, F., Greco, A., Perticone, M., Sciacqua, A., et al. (2014). A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. ATHEROSCLEROSIS, 232(1), 25-30 [10.1016/j.atherosclerosis.2013.10.024]. Dettagli
  22. Marini, M., Frontoni, S., Succurro, E., Arturi, F., Fiorentino, T., Sciacqua, A., et al. (2013). Insulin clearance is associated with carotid artery intima-media thickness. ATHEROSCLEROSIS, 229(2), 453-458 [10.1016/j.atherosclerosis.2013.06.011]. Dettagli
  23. Mannino, G., Greco, A., De Lorenzo, C., Andreozzi, F., Marini, M., Perticone, F., et al. (2013). A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity. PLOS ONE, 8(12), e85483-e85483 [10.1371/journal.pone.0085483]. Dettagli
  24. Marini, M., Frontoni, S., Succurro, E., Arturi, F., Fiorentino, T., Sciacqua, A., et al. (2013). Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels. PLOS ONE, 8(10), e77440-e77440 [10.1371/journal.pone.0077440]. Dettagli
  25. Sciacqua, A., Marini, M., Hribal, M., Perticone, F., & Sesti, G. (2013). Association of insulin resistance indexes to carotid intima-media thickness. PLOS ONE, 8(1), e53968-e53968 [10.1371/journal.pone.0053968]. Dettagli
  26. Marini, M.A., Succurro, E., Castaldo, E., Cufone, S., Arturi, F., Sciacqua, A., et al. (2012). Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. DIABETES CARE, 35(5), 1144-1149 [10.2337/dc11-2032]. Dettagli
  27. Marini, M.A., Succurro, E., Frontoni, S., Mastroianni, S., Arturi, F., Sciacqua, A., et al. (2012). Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. DIABETES CARE, 35(4), 868-872 [10.2337/dc11-2181]. Dettagli
  28. Cardellini, M., Menghini, R., Luzi, A., Davato, F., Cardolini, I., D'Alfonso, R., et al. (2011). Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness. DIABETES, 60(12), 3265-3270 [10.2337/db11-0162]. Dettagli
  29. Morviducci, L., Di Flaviani, A., Lauria, A., Pitocco, D., Pozzilli, P., Suraci, C., et al. (2011). Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit. DIABETES TECHNOLOGY & THERAPEUTICS, 13(10), 1071-1074 [10.1089/dia.2011.0056]. Dettagli
  30. Succurro, E., Marini, M.A., Arturi, F., Grembiale, A., Fiorentino, T.V., Andreozzi, F., et al. (2011). Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects. THE AMERICAN JOURNAL OF CARDIOLOGY, 107(11), 1650-5-1655 [10.1016/j.amjcard.2011.01.055]. Dettagli
  31. Fiore, A., Marinoni, G.M., Piccione, A., Marini, M.A., D'Adamo, M., Lauro, R., et al. (2011). A rare cardiac finding in a morbidly obese patient with severe hypertension. INTERNAL AND EMERGENCY MEDICINE, 6(3), 241-244 [10.1007/s11739-010-0472-8]. Dettagli
  32. Hribal, M., Presta, I., Procopio, T., Marini, M., Stančáková, A., Kuusisto, J., et al. (2011). Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B. DIABETOLOGIA, 54(4), 795-802 [10.1007/s00125-010-2038-8]. Dettagli
  33. Castaldo, E., Sabato, D., Lauro, D., Sesti, G., & Marini, M. (2011). Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance. PLOS ONE, 6(12), e28312-e28312 [10.1371/journal.pone.0028312]. Dettagli
  34. Succurro, E., Andreozzi, F., Marini, M.A., Lauro, R., Hribal, M.L., Perticone, F., et al. (2009). Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 19(10), 713-719 [10.1016/j.numecd.2008.12.011]. Dettagli
  35. Succurro, E., Marini, M.A., Arturi, F., Grembiale, A., Lugarà, M., Andreozzi, F., et al. (2009). Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. ATHEROSCLEROSIS, 207(1), 245-249 [10.1016/j.atherosclerosis.2009.04.006]. Dettagli
  36. Presta, I., Andreozzi, F., Succurro, E., Marini, M.A., Laratta, E., Lauro, R., et al. (2009). IL-18 gene polymorphism and metabolic syndrome. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 19(2), 5-6 [10.1016/j.numecd.2008.10.002]. Dettagli
  37. Succurro, E., Marini, M.A., Grembiale, A., Lugara, M., Andreozzi, F., Sciacqua, A., et al. (2009). Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. DIABETES/METABOLISM RESEARCH AND REVIEWS, 25(4), 351-356 [10.1002/dmrr.951]. Dettagli
  38. Marini, A., Spoletini, I., Rubino, I., Ciuffa, M., Bria, P., Martinotti, G., et al. (2008). The language of schizophrenia: an analysis of micro and macrolinguistic abilities and their neuropsychological correlates. SCHIZOPHRENIA RESEARCH, 105(1-3), 144-155 [10.1016/j.schres.2008.07.011]. Dettagli
  39. Succurro, E., Marini, M.A., Frontoni, S., Hribal, M.L., Andreozzi, F., Lauro, R., et al. (2008). Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. OBESITY, 16(8), 1881-1886 [10.1038/oby.2008.308]. Dettagli
  40. Sesti, G., Andreozzi, F., Bonadonna, R.C., De Mattia, G., Leonetti, F., Luzi, L., et al. (2008). Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance: the GISIR database. DIABETES/METABOLISM RESEARCH AND REVIEWS, 24(2), 130-136 [10.1002/dmrr.775]. Dettagli
  41. Staiger, H., Stancáková, A., Zilinskaite, J., Vänttinen, M., Hansen, T., Marini, M.A., et al. (2008). A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study. DIABETES, 57(2), 514-517 [10.2337/db07-1254]. Dettagli
  42. Bonora, E., Capaldo, B., Perin, P.C., Del Prato, S., De Mattia, G., Frittitta, L., et al. (2008). Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects: the GISIR database. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 18(9), 624-631. Dettagli
  43. Succurro E., M.M. (2008). Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. OBESITY, 16(8), 1881-1886 [10.1038/oby.2008.308]. Dettagli
  44. Marini, M., Succurro, E., Frontoni, S., Hribal, M., Andreozzi, F., Lauro, R., et al. (2007). Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. DIABETES CARE, 30(8), 2145-2147 [10.2337/dc07-0419]. Dettagli
  45. Ludovico, O., Pellegrini, F., Di Paola, R., Minenna, A., Mastroianno, S., Cardellini, M., et al. (2007). Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk. OBESITY, 15(5), 1076-1081 [10.1038/oby.2007.617]. Dettagli
  46. Cardellini, M., Andreozzi, F., Laratta, E., Marini, M.A., Lauro, R., Hribal, M.L., et al. (2007). Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. DIABETES/METABOLISM RESEARCH AND REVIEWS, 23(2), 141-145 [10.1002/dmrr.679]. Dettagli
  47. Cardellini, M., Marini, M., Frontoni, S., Hribal, M., Andreozzi, F., Perticone, F., et al. (2007). Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM, 292(1), E347-E352 [10.1152/ajpendo.00291.2006]. Dettagli
  48. Cardellini, M., Andreozzi, F., Laratta, E., Marini, M.A., Lauro, R., Hribal, M.L., et al. (2007). Plasma interteukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. DIABETES/METABOLISM RESEARCH AND REVIEWS, 23(2), 141-145 [10.1002/dmrr.679]. Dettagli
  49. Scarpelli, D., Cardellini, M., Andreozzi, F., Laratta, E., Hribal, M.L., Marini, M.A., et al. (2006). Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. DIABETES, 55(5), 1529-1533 [10.2337/db06-0047]. Dettagli
  50. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432 [10.1161/01.ATV.0000196552.84475.fc]. Dettagli
  51. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M.A., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432. Dettagli
  52. Andreozzi, F., Laratta, E., Cardellini, M., Marini, M.A., Lauro, R., Hribal, M.L., et al. (2006). Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. DIABETES, 55(7), 2021-2024 [10.2337/db06-0063]. Dettagli
  53. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M.A., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432 [10.1161/01.ATV.0000196552.84475.fc]. Dettagli
  54. Cardellini, M., Perego, L., D'Adamo, M., Marini, M., Procopio, C., Hribal, M., et al. (2005). C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. DIABETES CARE, 28(8), 2007-2012. Dettagli
  55. Cardellini, M., Perego, L., D'Adamo, M., Marini, M.A., Procopio, C., Hribal, M.L., et al. (2005). C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. DIABETES CARE, 28(8), 2007-2012 [10.2337/diacare.28.8.2007]. Dettagli
  56. Mariani, L.M., Fusco, A., Turriziani, M., Veneziani, A., Marini, M.A., de Lorenzo, A., et al. (2005). Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity. HORMONE AND METABOLIC RESEARCH, 37(4), 242-245 [10.1055/s-2005-861410]. Dettagli
  57. Sesti, G., Sciacqua, A., Cardellini, M., Marini, M., Maio, R., Vatrano, M., et al. (2005). Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. DIABETES CARE, 28(1), 120-125 [10.2337/diacare.28.1.120]. Dettagli
  58. D'Adamo, M., Perego, L., Cardellini, M., Marini, M.A., Frontoni, S., Andreozzi, F., et al. (2004). The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. DIABETES, 53(7), 1905-1910 [10.2337/diabetes.53.7.1905]. Dettagli
  59. Sesti, G., Marini, M.A., Cardellini, M., Sciacqua, A., Frontoni, S., Andreozzi, F., et al. (2004). The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. DIABETES CARE, 27(6), 1394-1398. Dettagli
  60. Mariani, L.M., Marini, M.A., Veneziani, A., Bertoli, A., & Lauro, R. (2003). Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding. ACTA DIABETOLOGICA, 40 Suppl 1, S263-5 [10.1007/s00592-003-0082-2]. Dettagli
  61. Marini, M.A., Frontoni, S., Mineo, D., Bracaglia, D., Cardellini, M., De Nicolais, P., et al. (2003). The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 88(7), 3368-3371 [10.1210/jc.2002-021716]. Dettagli
  62. Sesti, G., Cardellini, M., Marini, M., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-1283 [10.2337/diabetes.52.5.1280]. Dettagli
  63. Sesti, G., Cardellini, M., Marini, M., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-3. Dettagli
  64. Sesti, G., Cardellini, M., Marini, M.A., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-1283. Dettagli
  65. D'Alfonso, R., Marini, M., Frittitta, L., Sorge, R., Frontoni, S., Porzio, O., et al. (2003). Polymorphisms of the insulin receptor subtrate-2 in patients with type 2 diabetes. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 88(1), 317-322 [10.1210/jc.2002-020807]. Dettagli
  66. D'Alfonso, R., Marini, M.A., Frittitta, L., Sorge, R., Frontoni, S., Porzio, O., et al. (2003). Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 88(1), 317-22. Dettagli
  67. D'Alfonso, R., Marini, M.A., Frittitta, L., Sorge, R., Frontoni, S., Porzio, O., et al. (2003). Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 88(1), 317-322. Dettagli
  68. Mariani, L.M., Marini, M.A., Veneziani, A., Bertoli, A., & Lauro, R. (2003). Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding. In Acta Diabetologica [10.1007/s00592-003-0082-2]. Dettagli
  69. Sesti G., C.M. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES [10.2337/diabetes.52.5.1280]. Dettagli
  70. Bertoli, A., Magnaterra, R., Borboni, P., Marini, M.A., Barini, A., Fusco, A., et al. (1998). Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity. HORMONE RESEARCH, 49(1), 17-21. Dettagli
  71. Federici, M., Porzio, O., Zucaro, L., Giovannone, B., Borboni, P., Marini, M.A., et al. (1997). Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 135(1), 41-7. Dettagli
  72. Federici, M., Porzio, O., Zucaro, L., Giovannone, B., Borboni, P., Marini, M.A., et al. (1997). Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue front NIDDM patients. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 135(1), 41-47. Dettagli
  73. Sesti, G., D'Alfonso, R., Vargas Punti, M., Tullio, A., Liu, Y., Federici, M., et al. (1996). Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects. DIABETOLOGIA, 39(3), 289-297. Dettagli
  74. Bertoli, A., Fusco, A., Magnani, A., Marini, M., Di Daniele, N., Gatti, S., et al. (1995). Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103(1), 15-20 [10.1055/s-0029-1211324]. Dettagli
  75. Bertoli, A., Fusco, A., Magnani, A., Marini, M.A., Di Daniele, N., Gatti, S., et al. (1995). Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103(1), 15-20. Dettagli
  76. Sesti, G., Tullio, A., D'Alfonso, R., Napolitano, M., Marini, M., Borboni, P., et al. (1994). Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein. ACTA DIABETOLOGICA, 31(2), 59-65. Dettagli
  77. Sesti, G., Tullio, A., D'Alfonso, R., Napolitano, M., Marini, M.a., Borboni, P., et al. (1994). Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein. ACTA DIABETOLOGICA, 31(2), 59-65. Dettagli
  78. Sesti, G., Tullio, A., Marini, M., Manera, E., Borboni, P., Accili, D., et al. (1994). Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 101(1-2), 121-7. Dettagli
  79. Urbani, A., Bongiorno, L., Marini, M., Bolacchi, F., Zona, C., & Roda, L. (1994). Effect of differentiation on hydrolysis and association of Leu-enkephalin to K562(S) cells. PEPTIDES, 15(7), 1213-1222. Dettagli
  80. Urbani, A., Bongiorno, L., Marini, M., Zona, C., & Roda, L. (1994). Hydrolysis of leucine enkephalin and its association to the K562(S) erythroleukaemic cell line. IMMUNOPHARMACOLOGY, 27(2), 119-130. Dettagli
  81. Sesti, G., Marini, M., Briata, P., Tullio, A., Montemurro, A., Borboni, P., et al. (1992). Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 86(1-2), 111-8. Dettagli
  82. Sesti, G., Marini, M.A., Montemurro, A., Condorelli, L., Borboni, P., Haring, H.U., et al. (1992). Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. DIABETES, 41(1), 6-11. Dettagli
  83. Sesti, G., Marini, M.A., Tullio, A.N., Montemurro, A., Borboni, P., Fusco, A., et al. (1991). Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 181(3), 1419-24. Dettagli
  84. Sesti, G., Marini, M., Montemurro, A., Borboni, P., Di Cola, G., Bertoli, A., et al. (1991). Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 14(11), 913-918. Dettagli
  85. De Pirro, R., Borboni, P., Marini, M.A., Montemurro, A., Sesti, G., & Lauro, R. (1990). Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 13(11), 951-68. Dettagli
  86. Borboni, P., Di Cola, G., Sesti, G., Marini, M., Del Porto, P., Gilardini Montani, M., et al. (1989). Beta-endorphin receptors on cultured and freshly isolated lymphocytes from normal subjects. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 163(1), 642-8. Dettagli
  87. Bertoli, A., Caputo, S., Marini, M.A., Santini, S.A., Ghirlanda, G., & Greco, A.V. (1989). Inhibition of basal insulin secretion induces insulin resistance in normal man: evidence for a tonic effect of insulin on carbohydrate metabolism. HORMONE RESEARCH, 31(5-6), 238-43. Dettagli
  88. Caputo, S., Bertoli, A., Marini, M., Santini, G., Ghirlanda, G., & Greco, A. (1988). [Insulin secretion and insulin resistance in patients failing to respond to oral hypoglycemic agents]. MINERVA ENDOCRINOLOGICA, 13(3), 167-172. Dettagli
  89. Sesti, G., Marini, M., Montemurro, A., Di Daniele, N., Bertoli, A., Cordera, R., et al. (1988). [Preparation of 125I-labelled monoclonal antibodies of the insulin receptor]. COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 182(2), 167-76. Dettagli